[Form 4] Moderna, Inc. Insider Trading Activity
Filing: Form 4 filed for Moderna, Inc. (MRNA) reporting the vesting and conversion of restricted stock units into common stock by Director David M. Rubenstein.
Key facts: On 08/05/2025 850 restricted stock units vested and converted one-for-one into 850 shares of common stock at a price of $0. Following the transaction, the reporting person beneficially owned 1,527 shares. The Form 4 was signed by attorney-in-fact James Dillon on 08/06/2025. The filing indicates a direct ownership form and uses transaction code M with no other transactions disclosed.
Filing: Presentato il Form 4 per Moderna, Inc. (MRNA) che segnala la maturazione e la conversione di unit脿 azionarie ristrette in azioni ordinarie da parte del Direttore David M. Rubenstein.
Key facts: In data 08/05/2025 850 unit脿 azionarie ristrette sono maturate e convertite in rapporto uno a uno in 850 azioni ordinarie al prezzo di $0. Dopo l'operazione, la persona segnalante deteneva beneficiariamente 1,527 azioni. Il Form 4 猫 stato firmato per procura da James Dillon il 08/06/2025. La comunicazione indica una forma di propriet脿 diretta e utilizza il codice transazione M, senza altre operazioni dichiarate.
Filing: Se present贸 el Form 4 para Moderna, Inc. (MRNA) informando la consolidaci贸n y conversi贸n de unidades restringidas de acciones en acciones ordinarias por el Director David M. Rubenstein.
Key facts: El 08/05/2025 850 unidades restringidas vencieron y se convirtieron uno a uno en 850 acciones ordinarias a un precio de $0. Tras la operaci贸n, la persona informante pose铆a beneficiariamente 1,527 acciones. El Form 4 fue firmado por apoderado James Dillon el 08/06/2025. La presentaci贸n indica una forma de propiedad directa y utiliza el c贸digo de transacci贸n M, sin que se declaren otras transacciones.
Filing: Moderna, Inc. (MRNA)鞐� 雽�頃� Form 4臧� 鞝滌稖霅橃棃鞙茧┌ 鞚挫偓电� David M. Rubenstein鞚� 鞝滍暅欤检嫕雼渼(RSU) 甓岆Μ頇曥爼 氚� 氤错喌欤� 鞝勴櫂鞚� 氤搓碃頃╇媹雼�.
Key facts: 08/05/2025鞐� 850臧滌潣 鞝滍暅欤检嫕雼渼臧� 甓岆Μ頇曥爼霅橃柎 1雽�1 牍勳湪搿� 850欤检潣 氤错喌欤茧 鞝勴櫂霅橃棃鞙茧┌ 臧�瓴╈潃 $0鞛呺媹雼�. 瓯半灅 頉� 氤搓碃鞛惖鐢 順滍儩鞝� 氤挫湢 旮办鞙茧 1,527欤茧ゼ 氤挫湢頃橁碃 鞛堨棃鞀惦媹雼�. 頃措嫻 Form 4电� 08/06/2025鞐� 雽�毽秾鞛� James Dillon鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�. 鞝滌稖靹湹鐢 歆侅爲 靻岇湢 順曧儨毳� 雮橅儉雮措┌ 瓯半灅 旖旊摐 M毵� 旮办灛霅橃柎 鞛堦碃 雼るジ 瓯半灅电� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.
Filing: D茅p么t du Form 4 pour Moderna, Inc. (MRNA) signalant la consolidation et la conversion d'unit茅s d'actions restreintes en actions ordinaires par l'administrateur David M. Rubenstein.
Key facts: Le 08/05/2025, 850 unit茅s d'actions restreintes ont acquis droit et ont 茅t茅 converties une pour une en 850 actions ordinaires au prix de $0. Apr猫s la transaction, la personne d茅clarante d茅tenait b茅n茅ficiairement 1,527 actions. Le Form 4 a 茅t茅 sign茅 par le mandataire James Dillon le 08/06/2025. Le d茅p么t indique une forme de propri茅t茅 directe et utilise le code de transaction M, sans autres op茅rations divulgu茅es.
Filing: Es wurde ein Form 4 f眉r Moderna, Inc. (MRNA) eingereicht, das die F盲lligkeit und Umwandlung von Restricted Stock Units in Stammaktien durch den Direktor David M. Rubenstein meldet.
Key facts: Am 08/05/2025 sind 850 Restricted Stock Units f盲llig geworden und wurden eins zu eins in 850 Stammaktien zum Preis von $0 umgewandelt. Nach der Transaktion hielt die meldende Person wirtschaftlich 1,527 Aktien. Das Form 4 wurde am 08/06/2025 vom Bevollm盲chtigten James Dillon unterzeichnet. Die Meldung gibt direkte Eigentumsverh盲ltnisse an und verwendet den Transaktionscode M, weitere Transaktionen werden nicht angegeben.
- 850 restricted stock units vested and converted to 850 common shares on 08/05/2025
- Form 4 was filed and signed promptly (08/06/2025) reporting the change in direct beneficial ownership
- Post-transaction direct beneficial ownership is clearly disclosed as 1,527 shares
- None.
Insights
TL;DR: Routine equity compensation vesting by a director; disclosed via timely Form 4 filing.
The filing documents the conversion of 850 restricted stock units into 850 common shares for Director David M. Rubenstein on 08/05/2025. The report shows direct beneficial ownership of 1,527 shares post-transaction and is signed 08/06/2025. From a governance perspective, this is a standard disclosure of executive/director compensation and ownership changes, consistent with Section 16 reporting obligations. No related-party transfers, sales, or other governance concerns are disclosed in the form.
TL;DR: Transaction reflects vesting of awarded RSUs; filing provides clear, limited impact data for investors.
The Form 4 reports the vesting and one-for-one conversion of 850 RSUs into common stock (transaction code M) at a stated price of $0, with total direct beneficial ownership of 1,527 shares after the event. The disclosure is concise and limited to the single event; no purchases, sales, or derivative activity beyond the conversion are reported. Impact on outstanding shares or material financial metrics is not provided in the filing.
Filing: Presentato il Form 4 per Moderna, Inc. (MRNA) che segnala la maturazione e la conversione di unit脿 azionarie ristrette in azioni ordinarie da parte del Direttore David M. Rubenstein.
Key facts: In data 08/05/2025 850 unit脿 azionarie ristrette sono maturate e convertite in rapporto uno a uno in 850 azioni ordinarie al prezzo di $0. Dopo l'operazione, la persona segnalante deteneva beneficiariamente 1,527 azioni. Il Form 4 猫 stato firmato per procura da James Dillon il 08/06/2025. La comunicazione indica una forma di propriet脿 diretta e utilizza il codice transazione M, senza altre operazioni dichiarate.
Filing: Se present贸 el Form 4 para Moderna, Inc. (MRNA) informando la consolidaci贸n y conversi贸n de unidades restringidas de acciones en acciones ordinarias por el Director David M. Rubenstein.
Key facts: El 08/05/2025 850 unidades restringidas vencieron y se convirtieron uno a uno en 850 acciones ordinarias a un precio de $0. Tras la operaci贸n, la persona informante pose铆a beneficiariamente 1,527 acciones. El Form 4 fue firmado por apoderado James Dillon el 08/06/2025. La presentaci贸n indica una forma de propiedad directa y utiliza el c贸digo de transacci贸n M, sin que se declaren otras transacciones.
Filing: Moderna, Inc. (MRNA)鞐� 雽�頃� Form 4臧� 鞝滌稖霅橃棃鞙茧┌ 鞚挫偓电� David M. Rubenstein鞚� 鞝滍暅欤检嫕雼渼(RSU) 甓岆Μ頇曥爼 氚� 氤错喌欤� 鞝勴櫂鞚� 氤搓碃頃╇媹雼�.
Key facts: 08/05/2025鞐� 850臧滌潣 鞝滍暅欤检嫕雼渼臧� 甓岆Μ頇曥爼霅橃柎 1雽�1 牍勳湪搿� 850欤检潣 氤错喌欤茧 鞝勴櫂霅橃棃鞙茧┌ 臧�瓴╈潃 $0鞛呺媹雼�. 瓯半灅 頉� 氤搓碃鞛惖鐢 順滍儩鞝� 氤挫湢 旮办鞙茧 1,527欤茧ゼ 氤挫湢頃橁碃 鞛堨棃鞀惦媹雼�. 頃措嫻 Form 4电� 08/06/2025鞐� 雽�毽秾鞛� James Dillon鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�. 鞝滌稖靹湹鐢 歆侅爲 靻岇湢 順曧儨毳� 雮橅儉雮措┌ 瓯半灅 旖旊摐 M毵� 旮办灛霅橃柎 鞛堦碃 雼るジ 瓯半灅电� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.
Filing: D茅p么t du Form 4 pour Moderna, Inc. (MRNA) signalant la consolidation et la conversion d'unit茅s d'actions restreintes en actions ordinaires par l'administrateur David M. Rubenstein.
Key facts: Le 08/05/2025, 850 unit茅s d'actions restreintes ont acquis droit et ont 茅t茅 converties une pour une en 850 actions ordinaires au prix de $0. Apr猫s la transaction, la personne d茅clarante d茅tenait b茅n茅ficiairement 1,527 actions. Le Form 4 a 茅t茅 sign茅 par le mandataire James Dillon le 08/06/2025. Le d茅p么t indique une forme de propri茅t茅 directe et utilise le code de transaction M, sans autres op茅rations divulgu茅es.
Filing: Es wurde ein Form 4 f眉r Moderna, Inc. (MRNA) eingereicht, das die F盲lligkeit und Umwandlung von Restricted Stock Units in Stammaktien durch den Direktor David M. Rubenstein meldet.
Key facts: Am 08/05/2025 sind 850 Restricted Stock Units f盲llig geworden und wurden eins zu eins in 850 Stammaktien zum Preis von $0 umgewandelt. Nach der Transaktion hielt die meldende Person wirtschaftlich 1,527 Aktien. Das Form 4 wurde am 08/06/2025 vom Bevollm盲chtigten James Dillon unterzeichnet. Die Meldung gibt direkte Eigentumsverh盲ltnisse an und verwendet den Transaktionscode M, weitere Transaktionen werden nicht angegeben.
FAQ
What did the Form 4 for Moderna (MRNA) report?
How many shares does David M. Rubenstein beneficially own after the transaction?
What was the price of the shares issued on vesting?
When was the Form 4 signed and filed?
What transaction code was used on the Form 4?
